Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration crawled time : 22:01 save search
Mereo BioPharma and Ultragenyx Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta
Published: 2020-12-17 (Crawled : 22:01) - biospace.com/
RARE | News F | $42.37 -2.33% -2.38% 680K
|
Health Technology
|
| O: 0.73%
H: 3.04%
C: 1.56%
MREO | $2.64 -0.38% -0.38% 910K
|
Health Technology
|
| O: 2.78%
H: 1.8%
C: -0.45%
biopharma license collaboration announces collaboration
Ultragenyx and Mereo BioPharma Announce Collaboration and License Agreement for Setrusumab in Osteogenesis Imperfecta
Published: 2020-12-17 (Crawled : 22:01) - biospace.com/
RARE | News F | $42.37 -2.33% -2.38% 680K
|
Health Technology
|
| O: 0.73%
H: 3.04%
C: 1.56%
MREO | $2.64 -0.38% -0.38% 910K
|
Health Technology
|
| O: 2.78%
H: 1.8%
C: -0.45%
biopharma license collaboration announces collaboration
Zymeworks Announces Expansion of Zanidatamab Pivotal Trial in HER2-Amplified Biliary Tract Cancer in Asia in Collaboration With BeiGene
Published: 2020-12-01 (Crawled : 22:01) - biospace.com/
ZYME | $8.85 2.08% 2.03% 550K
|
Health Technology
|
| O: 1.35%
H: 4.47%
C: 2.44%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 1.69%
H: 0.96%
C: -5.2%
collaboration cancer trial expansion her2+ her2- her2
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.